Cummins Inc to pay $1.7B in Ram Emissions Suit
Engine manufacturer Cummins Inc. has reached a groundbreaking $1.675 billion settlement with the federal government and the state of California, resolving allegations of emission limit violations through the installation of…
By – Rihem AkkoucheLatest news
Investment Co To Block KKR’s £1.3B Smart Meter Deal
In a dramatic turn of events, PrimeStone Capital LLP, an investment company led by Alan Foy and Steve…
By Rihem AkkoucheHarbour Energy To Buy Asset Portfolio For $11.2B
Harbour Energy PLC, based in Edinburgh, Scotland, has set the stage for a blockbuster move by announcing its…
By Rihem AkkoucheRudy Giuliani Files For Bankruptcy Amidst Defamation Fallout
In a stunning turn of events, Rudy Giuliani, a prominent ally of former President Donald Trump, has filed…
By Rihem AkkoucheNigeria $11B Arbitration Award Set Aside Due to Fraud
In a shocking turn of events, a London court stood firm on Thursday, refusing to reconsider an $11…
By Rihem AkkoucheMedical Device Cos Settle Trade Secrets Suit For $8M
In a legal saga that unfolded like a spine-tingling thriller, medical device juggernaut Aegis Spine Inc. has agreed…
By Rihem AkkoucheBaker Botts Wants $6M From Foley Lardner
Telecom giant Dish, backed by legal powerhouse Baker Botts LLP, is intensifying its legal battle against Foley &…
By Rihem AkkoucheSeafood Co Wants $500K In Fees After Prevailing in Lawsuit
In a legal battle that unfolded like a high-stakes chess match, Inland Fresh Seafood Corp. of America Inc.,…
By Rihem AkkoucheMassachusetts Board $22M Assessment For Cargo Facility
In a dramatic move, the U.S. Supreme Court has announced the scheduling of oral arguments for February in…
By Rihem AkkoucheClaimants Vie Amazon £900M Class Action
In a dramatic courtroom clash, two proposed class representatives stood before Britain’s antitrust tribunal, each vying to lead…
By Rihem Akkouchepharma co goes bankrupt with $127M Debt
In a shocking turn of events, renowned migraine drug manufacturer Impel Pharmaceuticals Inc. and its subsidiary, Impel NeuroPharma…
By Rihem Akkouche